OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

25 hedge funds and large institutions have $13.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$945K
2
+$467K
3
+$336K
4
ACA
Apis Capital Advisors
New York
+$237K
5
Renaissance Technologies
Renaissance Technologies
New York
+$212K

Top Sellers

1
-$272K
2
-$254K
3
-$191K
4
SCM
Stonepine Capital Management
Oregon
-$19.4K
5
BlackRock
BlackRock
New York
-$3.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
1
2